Akathisia Management: 2026 PMHNP Decision Tree
Akathisia gets misread as anxiety in up to half of cases. The 2026 PMHNP decision tree: BARS scoring, mirtazapine vs. propranolol, what to never miss.
Real talk about psychopharmacology, clinical confidence, and building a practice you love — from Lindsay and the Fellowship faculty.
More Articles
Akathisia gets misread as anxiety in up to half of cases. The 2026 PMHNP decision tree: BARS scoring, mirtazapine vs. propranolol, what to never miss.
A QTc above 500 ms triples the risk of torsades. Here's the 2026 PMHNP protocol for screening, monitoring, and acting on psychotropic-driven QT prolongation.
NHSC, IHS, PSLF, and state programs can wipe $50K to $80K of PMHNP student debt in 2026. Here's which to apply for first, deadlines, and the trap to avoid.
Up to 40 percent of bipolar diagnoses don't hold on reassessment. Here's the 5-step PMHNP confidence script for reassessing an inherited diagnosis in 2026.
Bipolar diagnosis takes 6+ years on average. A 2026 PMHNP confidence playbook: the delivery script, the MDQ pitfalls, and the chart language that holds up.
The first solo suicide risk assessment rattles most new PMHNPs. A 2026 playbook: the C-SSRS questions, the Stanley-Brown plan, and chart language that holds up.
A new PMHNP confidence script for declining inappropriate controlled substance requests — with exact language, rationale, and de-escalation frameworks.
Clinical decision fatigue hits new PMHNPs hard. Learn why your brain stalls after back-to-back patients and how to protect your prescribing confidence.